Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
AstraZeneca
Age
20–any
Sex
MALE
Healthy volunteers
Not accepted
You may be eligible if
Males aged 20 years or older.
Histologically or Cytologically proven diagnosis of prostate cancer for which no standard therapy is currently considered appropriate
Documented evidence of metastatic prostate cancer
Serum testosterone concentration ≤50 ng/dL
World Health Organisation (WHO) performance status 0 to 1 with no deterioration over the previous 2 weeks and minimum life expectancy of 12 weeks
You may not be if
History of hypersensitivity to active or inactive excipients of AZD3514 or drugs with a similar chemical structure or class to AZD3514
Refractory nausea and vomiting, chronic gastrointestinal diseases, inability to swallow the formulated product or previous significant bowel resection that would preclude adequate absorption of AZD3514
Inadequate bone marrow reserve or organ function
Concurrent or recent treatment with certain medications or medical procedures
Any medically important factors identified from electrocardiogram (ECG) measurements
Clareo Health | An Open Label Prostate Cancer Study in Japanese Patients
